Pharma & Biotech Patent Litigation in Europe
30-31 May 2022
For the past 15 years, only one industry-shaping event has consistently brought together the “Who’s Who” of the European Life Sciences Patent Bar… C5’s Pharma & Biotech Patent Litigation in Europe.
Peter Ling will be speaking on a panel about the most recent developments on Compulsory Licensing: Access to Medicines, the TRIPS Agreement and Vaccines.
For more information, please refer to the website.